Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-836-6 | CAS number: 7758-19-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Chlorine dioxide and chlorite are characterized together for the genetic toxicity because studies conducted with chlorite, the predominant degradation product of chlorine dioxide, are likely relevant to characterizing the toxicity of chlorine dioxide. In addition, studies conducted with chlorine dioxide may be relevant to characterizing the toxicity of chlorite. Chlorine dioxide is fairly unstable and rapidly dissociates, predominantly into chlorite and chloride, and to a lesser extent, chlorate. There is a ready interconversion among these species in water.
Genetic toxicity in vitro:
Bacterial reverse mutation assay: Ames tests: Test method similar to OECD guideline 471:
Weight of evidence: Experimental results: Sodium chlorite was negative when tested with the Salmonella typhimurium strains TA97 and TA102, with and without metabolic activation. Sodium chlorite was negative when tested with the Salmonella typhimurium strains TA 92, TA 1535, TA 1537, TA 94 and TA 98, with and without metabolic activation. Sodium chlorite was positive in S. typhimurium strain TA 100 with metabolic activation.
Chromosomal aberrations: Test method similar to OECD guideline 473:
Supporting study: Experimental results: Sodium chlorite was positive in the chromosome test without metabolic activation. However, no data on positive controls are provided. In vivo studies on chromosomal aberrations are available.
Gene mutation in mammalian cells: Test method similar to OECD guideline 476:
Key study: Experimental results with the substance chlorine dioxide. The test substance chlorine dioxide is considered active in the Mouse Lymphoma Forward Mutation Assay in the presence and absence of metabolic activation.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Chlorine dioxide and chlorite are characterized together for the genetic toxicity because studies conducted with chlorite, the predominant degradation product of chlorine dioxide, are likely relevant to characterizing the toxicity of chlorine dioxide. In addition, studies conducted with chlorine dioxide may be relevant to characterizing the toxicity of chlorite. Chlorine dioxide is fairly unstable and rapidly dissociates, predominantly into chlorite and chloride, and to a lesser extent, chlorate. There is a ready interconversion among these species in water.
Genetic toxicity in vivo:
Key study: In vivo Mammalian Alkaline Comet Assay (OECD 489, GLP). Sodium chlorite resulted to be negative in liver and duodenum. In the contrary, the substance induced DNA-strand breaks in glandular stomach. Sodium Chlorite caused degenerative inflammatory and reactive changes in the stomach of several dosed animals. The overall cause of the gastric changes was the irritative action of the test item on the glandular stomach mucosa. Comparing the individual Comet Assay results with the individual histopathology data, there is a correlation between the severity of the observed gastric changes and the results of the Comet assay for High Group animals. Further testing is deemed necessary in order to conclude whether the observed effects are due to cytotoxicity and/or genotoxicity.
Weight of evidence: Experimental results. Data provided are based on bone marrow chromosome aberration tests and micronucleus tests.
Micronucleus assay: publications from two different authors. Test methods similar to OECD guideline 474:
Hayashi et al. (1988): In the single ip treatment, positive results were obtained for sodium chlorite. Sodium chlorite failed to show a statistically significant result after administration by oral gavage. After four ip injections at a dose level of 15 mg/kg bw, negative results were obtained for sodium chlorite.
Meier et al. (1985): After oral administration, none of the dose levels tested gave significant increases for either pooled or individual sex data.
Chromosomal aberrations: data from a publication. Test method similar to OECD guideline 475:
Meier et al. (1988): after oral single administration and multiple oral administration there were no significant differences from control for any of the treatment groups in either structural or numerical chromosomal aberrations.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
A positive result was observed in an in vivo micronucleus assay in somatic cells exposed by the intraperitoneal route. In this case, there are additional data from in vivo tests with oral administration of the test substance showing negative results and the weight of evidence approach has been applied. Furthermore, data from an in vivo study on chromosomal aberrations in somatic cells by the oral route also showed negative results. It seems that genotoxicity can only be shown at internal body substance concentrations which cannot be achieved using application routes other than intraperitoneal. Furthermore, the intraperitoneal route of exposure is not relevant for human exposure.
In an In vivo Mammalian Alkaline Comet Assay, sodium chlorite resulted to be negative in liver and duodenum. In the contrary, the substance induced DNA-strand breaks in glandular stomach. Sodium chlorite caused degenerative inflammatory and reactive changes in the stomach of several dosed animals. The overall cause of the gastric changes was the irritative action of the test item on the glandular stomach mucosa. Comparing the individual Comet Assay results with the individual histopathology data, there is a correlation between the severity of the observed gastric changes and the results of the Comet assay for High Group animals. In the present case, further testing was deemed necessary in order to conclude whether the observed effects are due to cytotoxicity and/or genotoxicity.
Hazard classification for germ cell mutagenicity primarily aims to identify substances causing heritable mutations or being suspected of causing heritable mutations. Therefore, this hazard class is primarily concerned with substances that may cause mutations in the germ cells of humans that can be transmitted to the progeny. Based on the available information from different publications from independent sources, on toxicity to reproduction studies and developmental toxicity studies, it can be concluded that the substance showed no evidence of reproductive toxicity.
It is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects. Based on the available information from different publications from independent sources, on oral studies with rats and mice by administration in drinking water and dermal studies with female mice it can be concluded that the substance showed no evidence of carcinogenic activity.
Therefore, based on all these arguments, it is concluded that the substance is not classified for germ cell mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.